Corporate News     21-Dec-21
Shilpa Medicare launches PRUCALSHIL (Prucalopride) Orally Disintegrating Strips in India
Shilpa Medicare has launched PRUCALSHIL (Prucalopride) Orally Disintegrating Strips 1 mg and 2 mg in India, a unique formulation developed for the first time in the World. The company has developed a novel ‘Orally Disintegrating Strip (ODS)' formulation for Prucalopride and obtained subsequent approval from Drug Control General of India.

Prucalopride is used for symptomatic treatment of chronic constipation in adults in whom laxatives fail to provide adequate relief.

Prucalopride medicine in the form of Orally Disintegrating Strips are most convenient dosage form for geriatric patients. Orally Disintegrating Strips have an advantage such as greater dissolution due to large surface area, more patient compliance than oral tablets, no risk of choking & better taste masking etc.

Previous News
  Shilpa Medicare gets tentative approval for hepatitis drug
 ( Hot Pursuit - 16-Sep-22   14:32 )
  Shilpa Medicare gains on concluding human clinical studies of Adalimumab biosimilar
 ( Hot Pursuit - 22-Aug-22   13:24 )
  Shilpa Medicare gets Europe approval for Varenicline tablets
 ( Hot Pursuit - 26-Feb-24   12:05 )
  Shilpa Medicare to declare Quarterly Result
 ( Corporate News - 07-Nov-23   14:09 )
  Shilpa Medicare standalone net profit declines 20.37% in the September 2021 quarter
 ( Results - Announcements 29-Oct-21   17:11 )
  Shilpa Medicare standalone net profit rises 3.16% in the September 2020 quarter
 ( Results - Announcements 02-Nov-20   14:07 )
  Shilpa Medicare Ltd leads losers in 'A' group
 ( Hot Pursuit - 20-Feb-23   15:00 )
  Board of Shilpa Medicare approves acquisiton of stakeholding in two entities
 ( Corporate News - 16-Jun-20   15:18 )
  Shilpa Medicare consolidated net profit declines 56.02% in the September 2021 quarter
 ( Results - Announcements 29-Oct-21   18:15 )
  Shilpa Medicare consolidated net profit declines 10.63% in the September 2020 quarter
 ( Results - Announcements 02-Nov-20   15:17 )
  Shilpa Medicare standalone net profit rises 15.73% in the June 2017 quarter
 ( Results - Announcements 10-Aug-17   16:48 )
Other Stories
  Board of Delhivery approves alteration in capital clause of MoA
  05-Jul-24   19:32
  J B Chemicals & Pharmaceuticals appoints director
  05-Jul-24   19:30
  Infosys announces resignation of senior management personnel
  05-Jul-24   19:22
  JLR Q1 FY25 retail sales up 9% on YoY basis
  05-Jul-24   19:08
  Bajaj Auto launches world's first CNG motorcycle 'Freedom'
  05-Jul-24   18:59
  Agenda for board meeting of Power Grid Corporation of India
  05-Jul-24   18:46
  Board of Bank of Baroda approves raising additional capital up to Rs 7,500 cr in FY25
  05-Jul-24   18:06
  Vipul to hold board meeting
  05-Jul-24   17:15
  Markobenz Ventures to convene board meeting
  05-Jul-24   17:15
  Dhanashree Electronics to declare Quarterly Result
  05-Jul-24   17:15
Back Top